Combination Chemotherapy and Thalidomide in Treating Patients With Stage I, Stage II, or Stage III Multiple Myeloma

NCT00054158 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma and Plasma Cell Neoplasm

Interventions

DRUG: dexamethasone
DRUG: doxorubicin hydrochloride
DRUG: thalidomide
DRUG: vincristine sulfate

Sponsor

Roswell Park Cancer Institute